Prophylaxis for Thromboembolism in Critical Care Trial - PROTECT (Dalteparin vs. UFH)

Description:

The goal of the trial was to compare treatment with a low-molecular weight heparin (LMWH) compared with unfractionated heparin (UFH) in critically ill patients.